266 related articles for article (PubMed ID: 30292735)
1. A punch in the gut - Intestinal inflammation links environmental factors to neurodegeneration in Parkinson's disease.
Becker A; Faßbender K; Oertel WH; Unger MM
Parkinsonism Relat Disord; 2019 Mar; 60():43-45. PubMed ID: 30292735
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory Bowel Diseases and Parkinson's Disease.
Brudek T
J Parkinsons Dis; 2019; 9(s2):S331-S344. PubMed ID: 31609699
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease and Parkinson's disease: common pathophysiological links.
Lee HS; Lobbestael E; Vermeire S; Sabino J; Cleynen I
Gut; 2021 Feb; 70(2):408-417. PubMed ID: 33067333
[TBL] [Abstract][Full Text] [Related]
4. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease.
Aho VTE; Houser MC; Pereira PAB; Chang J; Rudi K; Paulin L; Hertzberg V; Auvinen P; Tansey MG; Scheperjans F
Mol Neurodegener; 2021 Feb; 16(1):6. PubMed ID: 33557896
[TBL] [Abstract][Full Text] [Related]
5. Is Parkinson's disease a chronic low-grade inflammatory bowel disease?
Rolli-Derkinderen M; Leclair-Visonneau L; Bourreille A; Coron E; Neunlist M; Derkinderen P
J Neurol; 2020 Aug; 267(8):2207-2213. PubMed ID: 30989372
[TBL] [Abstract][Full Text] [Related]
6. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
[TBL] [Abstract][Full Text] [Related]
7. Peripheral aetiopathogenic drivers and mediators of Parkinson's disease and co-morbidities: role of gastrointestinal microbiota.
Dobbs SM; Dobbs RJ; Weller C; Charlett A; Augustin A; Taylor D; Ibrahim MA; Bjarnason I
J Neurovirol; 2016 Feb; 22(1):22-32. PubMed ID: 26092111
[TBL] [Abstract][Full Text] [Related]
8. Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice.
Perez-Pardo P; Dodiya HB; Engen PA; Forsyth CB; Huschens AM; Shaikh M; Voigt RM; Naqib A; Green SJ; Kordower JH; Shannon KM; Garssen J; Kraneveld AD; Keshavarzian A
Gut; 2019 May; 68(5):829-843. PubMed ID: 30554160
[TBL] [Abstract][Full Text] [Related]
9. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
[TBL] [Abstract][Full Text] [Related]
10. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
[TBL] [Abstract][Full Text] [Related]
11. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease increases the risk of Parkinson's disease: a Danish nationwide cohort study 1977-2014.
Villumsen M; Aznar S; Pakkenberg B; Jess T; Brudek T
Gut; 2019 Jan; 68(1):18-24. PubMed ID: 29785965
[TBL] [Abstract][Full Text] [Related]
13. [The gut microbiome in Parkinson's disease].
Bedarf JR; Hildebrand F; Goeser F; Bork P; Wüllner U
Nervenarzt; 2019 Feb; 90(2):160-166. PubMed ID: 30171304
[TBL] [Abstract][Full Text] [Related]
14. Effects of a high saturated fatty acid diet on the intestinal microbiota modification and associated impacts on Parkinson's disease development.
de Queiroz Cavalcanti SA; de Almeida LA; Gasparotto J
J Neuroimmunol; 2023 Sep; 382():578171. PubMed ID: 37562163
[TBL] [Abstract][Full Text] [Related]
15. Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications.
Rani L; Mondal AC
Neurosci Res; 2021 Jul; 168():100-112. PubMed ID: 33417973
[TBL] [Abstract][Full Text] [Related]
16. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
17. Can the gut be the missing piece in uncovering PD pathogenesis?
Chapelet G; Leclair-Visonneau L; Clairembault T; Neunlist M; Derkinderen P
Parkinsonism Relat Disord; 2019 Feb; 59():26-31. PubMed ID: 30448099
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries.
Camacho-Soto A; Gross A; Searles Nielsen S; Dey N; Racette BA
Parkinsonism Relat Disord; 2018 May; 50():23-28. PubMed ID: 29459115
[TBL] [Abstract][Full Text] [Related]
20. Do Bacterial Outer Membrane Vesicles Contribute to Chronic Inflammation in Parkinson's Disease?
Koukoulis TF; Beauchamp LC; Kaparakis-Liaskos M; McQuade RM; Purnianto A; Finkelstein DI; Barnham KJ; Vella LJ
J Parkinsons Dis; 2024; 14(2):227-244. PubMed ID: 38427502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
